A leading visionary coordinator with a strong research track record in pediatric neurooncology
The Danish national research
program for brain tumors in childhood (5C) is seeking a leading visionary coordinator
with a strong research track record in pediatric neuro-oncology. You will be a
key figure in developing the area nationally.
The 5C project is a new
nationwide research program for pediatric brain tumors funded by the Danish
Childhood Cancer Foundation. The clinical
obligations of the position include diagnosis, treatment and follow-up of
children with brain tumors as part of the existing
pediatric oncology team at Rigshospitalet University Hospital in Copenhagen.
This posting is for a full-time position as consultant
at the Department of Pediatrics and Adolescent Medicine, Rigshospitalet
University Hospital, and as investigator and coordinator of the Danish national
research program for brain tumors in childhood – 5C; Danish Collaborative Comprehensive Childhood CNS tumor Consortium. The consultant will distribute his/her time 60%-40% between research and
clinical work within pediatric oncology.
The pediatric neuro-oncology team
at Rigshospitalet aims at developing research and treatment in the area of
pediatric brain tumors at the highest international level in cooperation with
the multi-disciplinary team at Aarhus University Hospital, Skejby, (co-funded
by this program) and existing research partners in Denmark and internationally.
The contract
period is 5 years, but can be made permanent.
Responsibilities
The clinical obligations of the
position include diagnosis, treatment and follow-up of children with brain
tumors as part of the existing pediatric
oncology team at Rigshospitalet University Hospital. The research obligations
include supervising and supporting the national 5C research program, which has
the following work packages
- etiology, pathogenesis and biology (incl. state-of-the-art molecular tumor classification);
- diagnostic delays;
- non-surgical diagnostic methods;
- patient-derived xenograft mouse models;
- improvement in surgical outcomes;
- innovative pharmacological strategies, incl. phase 1-2 trials;
- efficacy and toxicity of proton beam therapy;
- late effect research; and
- psychosocial and habilitation support during and after treatment.
Required Qualifications
The applicant must have a medical degree (M.D.) with
specialization in pediatrics and/or pediatric oncology, and his/her training
fulfils the EU curriculum for pediatric oncology. The candidate has a Ph.D. (or
similar). In addition, the applicant has
strong research track record
in pediatric neuro-oncology and additional experience in one or more of the
research areas listed above; basic science and translational research relevant
for pediatric neuro-oncology will be prioritized;
research leadership experience,
including coordination of multi-disciplinary projects
excellent verbal and written
communication skills.
The candidate should be visionary,
and emphasis is on innovative attitude, management skills, and collaborative
skills.
The applicant is expected to be able to learn Danish
within the first 6 months of the position to a level allowing communication
with patients and families.
Description of the department
The
Department of Pediatric Oncology and hematopoietic Stem cell Transplantation
(POST), Rigshospitalet
University Hospital, is the
largest Nordic children's cancerunit with approximately 10,000 hospital
bed admissions and approximately 8,000 outpatient visits annually.
POST is responsible for the diagnostic work-up,
treatment, and follow-up of more than 50% of all children with cancer 0-17.9
years of age in Denmark, including 2/3rd of children with brain
tumors. In Denmark, 180-200 children (0-17.9 years) are diagnosed with cancer
each year, of which POST receives 110-120, including 30 brain tumor patients. POST was the first center in the
Nordic region offering experimental treatments to childhood cancer patients as
partner in the ITCC network, and is currently the only phase I ITCC center in
the Nordic/Baltic region.
The pediatric CNS tumor
service at Rigshospitalet works as a multi-disciplinary team with close
collaboration between pediatric oncologists, pediatric neurosurgeons,
neuropathologists, molecular biologists, neuroradiologists and nuclear medicine
specialists, ophthalmologists, radiotherapy specialists, pediatric neurologists
and pediatric endocrinologists.
The medical staff consists
of 18 full-time pediatricians. POST’s research lab has two professors, 7
post-docs, 14 PhD-students, 9 lab.-technicians, and several research nurses, in
addition to project coordinators, IT manager, and biostatistician. The primary
research areas are cancer etiology (we perform whole genome sequencing of germline
DNA on all Danish childhood cancer patients), cancer biology, CNS tumors,
pharmacogenetics and pharmacokinetics of anticancer agents, toxicities
including inflammatory responses second to anticancer therapy, late effects,
rehabilitation, educational strategies, and nursing research. Together with the
Department of Neurosurgery, Rigshospitalet, we coordinate a large international
study on cerebellar mutism after fossa posterior brain tumor surgery recruiting
patients in 8 countries. Other active CNS tumor research projects include FET-PET
imaging of pediatric brain tumors, and late effect research. POST’s research
unit has close collaboration with the bioinformatic unit at the Danish
Technological University.
Internationally, POST has
strong research networks, including childhood cancer centers throughout the
Nordic and Baltic region, and twinning programs with University Hospital of
Southern Denmark, Odense, and with the University Hospital, Lund, Sweden, which
includes research collaboration and transfer of patients. POST received the Global Excellence
Award in 2013 and the Capital Region, Denmark, and the Skåne Region, Sweden’s
Öresund Award in 2014 for these activities.
Rigshospitalet University Hospital and the adjacent
Faculty of Health and Medical Science and the Faculty of Science, University of
Copenhagen, is home to excellent clinical and basic science environments (https://www.rigshospitalet.dk/english/Pages/default.aspx/
& https://introduction.ku.dk/organisation/faculties/). Furthermore, Copenhagen
is an amazing city with a rich academic history, an active student life as well
as an excellent quality of life for the entire family.
Salary and terms of employment:
Salary and terms of employment follow
current Danish agreements and regulation for similar position.
If you should require further
information you are most welcome to contact Professor Kjeld Schmiegelow tel:
+45 3545 1357 mail: Kjeld.Schmiegelow@regionh.dk, or consultant Susanne Bentkjaer +45 2125 2314
at Mercuri Urval, who is assisting 5C in this recruitment process.
How to Apply
A cover letter is required for consideration for this
position and should be attached as the first page of your resume / CV. The
cover letter should address your specific interest in the position and outline
skills and experience that directly relate to this position. The application should include relevant certificates.
Deadline for application is 23:59 pm, Monday, August 20, 2018.
”Apply for this position online here”
Rigshospitalet is a smoke-free workplace.
Rigshospitalet is part of the Capital Region of
Denmark.
-
Jobbet er udløbet...
- Føj til favoritter
- Læs om regionen
Fakta
- Arbejdssted
Rigshospitalet, Blegdamsvej - Adresse
Blegdamsvej 9, 2100 København Ø -
Kontaktperson
Kjeld Schmiegelow - Stillingstype
Overlæge - Speciale
Pædiatri - Ansættelsesform
Tidsbegrænset periode - Ugentlig arbejdstid
Fuld tid - Ansættelsens start
Snarest muligt - Regionens jobnr.
212506 - Quick-nr.
354699 - Indrykningsdato
11-07-2018 -
Ansøgningsfrist
20-08-2018 (udløbet)
Du er ikke logget ind
For at kunne oprette en jobagent på baggrund af dette job skal du først logge ind. Vil du logge ind nu?
Ja, tak! Opret bruger ×